drugset / Trial / NCT02426060
A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study was to determine the effects of Imrecoxib, an anti-infiammatory/analgesic agent that primarily inhibits COX-2 and not COX-1 at therapeutic doses, on the steady-state pharmacokinetic profile and hypoprothrombinemic effect of warfarin in healthy volunteers.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-03
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Imrecoxib | Small molecule | — | — |
| Subject | Warfarin | Small molecule | — | — |